{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:18Z","timestamp":1794047418653,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2022.281435","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:16:05Z","timestamp":1669299365000},"page":"1173-1178","source":"Crossref","is-referenced-by-count":1,"title":["Landscape of immunoglobulin heavy chain \u03b3 gene class switch recombination in patients with adult T-cell leukemia\u2013lymphoma"],"prefix":"10.3324","volume":"108","author":[{"given":"Hiroaki","family":"Hiramatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisato","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilseung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Makiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asahi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yonekura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiro","family":"Tatetsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youko","family":"Suehiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaji","family":"Matsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atae","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"46888","doi-asserted-by":"crossref","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leu-kemia: clinical and hematologic features of 16 cases. Blood. 1977; 50(3):481-492.","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481"},{"key":"46889","doi-asserted-by":"crossref","unstructured":"Ishii T, Ishida T, Utsunomiya A. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma. Clin Cancer Res. 2010; 16(5):1520-1531.","DOI":"10.1158\/1078-0432.CCR-09-2697"},{"key":"46890","doi-asserted-by":"crossref","unstructured":"Ishida T, Joh T, Uike N. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012; 30(8):837-842.","DOI":"10.1200\/JCO.2011.37.3472"},{"key":"46891","doi-asserted-by":"crossref","unstructured":"Ishida T, Jo T, Takemoto S. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol. 2015; 169(5):672-682.","DOI":"10.1111\/bjh.13338"},{"key":"46892","doi-asserted-by":"crossref","unstructured":"Yonekura K, Kusumoto S, Choi I. Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study. Blood Adv. 2020; 4(20):5133-5145.","DOI":"10.1182\/bloodadvances.2020003053"},{"key":"46893","doi-asserted-by":"crossref","unstructured":"Nosaka K, Kusumoto S, Nakano N. Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia-lymphoma patients receiving mogamulizumab. Br J Haematol. 2022; 196(3):629-638.","DOI":"10.1111\/bjh.17895"},{"key":"46894","doi-asserted-by":"crossref","unstructured":"Honjo T, Kataoka T. Organization of immunoglobulin heavy chain genes and allelic deletion model. Proc Natl Acad Sci U S A. 1978; 75(5):2140-2144.","DOI":"10.1073\/pnas.75.5.2140"},{"key":"46895","doi-asserted-by":"crossref","unstructured":"Xu Z, Zan H, Pone EJ, Mai T, Casali P. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol. 2012; 12(7):517-531.","DOI":"10.1038\/nri3216"},{"key":"46896","doi-asserted-by":"crossref","unstructured":"Westra ER, S\u00fcnderhauf D, Landsberger M, Buckling A. Mechanisms and consequences of diversity-generating immune strategies. Nat Rev Immunol. 2017; 17(11):719-728.","DOI":"10.1038\/nri.2017.78"},{"key":"46897","doi-asserted-by":"crossref","unstructured":"Kitaura K, Yamashita H, Ayabe H, Shini T, Matsutani T, Suzuki R. Different somatic hypermutation levels among antibody subclasses disclosed by a new next-generation sequencing-based antibody repertoire. Analysis. Front Immunol. 2017; 8:389.","DOI":"10.3389\/fimmu.2017.00389"},{"key":"46898","doi-asserted-by":"crossref","unstructured":"Mazumdar M, Glassman JR. Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med. 2000; 19(1):113-132.","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O"},{"key":"46899","doi-asserted-by":"crossref","unstructured":"Muramatsu M, Sankaranand VS, Anant S. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA editing deaminase family in germinal center B cells. J Biol Chem. 1999; 274(26):18470-18476.","DOI":"10.1074\/jbc.274.26.18470"},{"key":"46900","doi-asserted-by":"crossref","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation- induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000; 102(5):553-563.","DOI":"10.1016\/S0092-8674(00)00078-7"},{"key":"46901","doi-asserted-by":"crossref","unstructured":"Feng Y, Seija N, Di Noia JM, Martin A. AID in antibody diversification: there and back again. Trends Immunol. 2021; 42(1):89.","DOI":"10.1016\/j.it.2020.10.011"},{"key":"46902","doi-asserted-by":"crossref","unstructured":"Tanaka N, Mori S, Kiyotani K. Genomic determinants impacting clinical outcome of mogamulizumab treatment for adult T-cell leukemia\/lymphoma. Haematologica. 2022; 107(10):2418-2431.","DOI":"10.3324\/haematol.2021.280352"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281435\/75071","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281435\/75508","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10878\/75071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:02:50Z","timestamp":1794045770000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.281435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.281435","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,24]]}}}